[TVTX] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
27-Oct-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -3.91%
YoY- -95.45%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 37,095 53,496 68,217 51,139 44,373 40,706 40,340 -1.38%
PBT -89,229 -69,511 -35,596 -22,526 -37,013 -54,101 -19,017 29.37%
Tax -12 145 43 23 -523 415 -1,223 -53.71%
NP 150,735 -69,656 -35,639 -22,549 -36,490 -54,516 -17,794 -
Tax Rate - - - - - - - -
Total Cost -113,640 123,152 103,856 73,688 80,863 95,222 58,134 -
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 406.35 -130.21 -52.24 -44.09 -82.23 -133.93 -44.11 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.99 -1.09 -0.59 -0.44 -0.85 -1.34 -0.46 13.61%
EPS Diluted -0.99 -1.09 -0.59 -0.44 -0.85 -1.34 -0.46 13.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.